Jane Bryce

Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

Massimo Di Maïo, Ciro Gallo, Natasha B. Leighl et al. · Journal of Clinical Oncology · 2015 · 497 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +16

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy

Francesco Perrone, Claudio Jommi, Massimo Di Maïo et al. · Annals of Oncology · 2016 · 158 citations · Full text

Medicine, Oncology, Health Care Finance +12

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

Sandro Pignata, Giovanni Scambia, Alessandra Bologna et al. · Journal of Clinical Oncology · 2017 · 90 citations

Medicine, Gynecology, Oncology +13

Inhibition of stromal CXCR4 impairs development of lung metastases

Crescenzo D’Alterio, Antônio Barbieri, Luigi Portella et al. · Cancer Immunology Immunotherapy · 2012 · 59 citations · Full text

Medicine, Oncology, Pharmacology +14

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Madeleine King, Martin R. Stockler, Rachel O’Connell et al. · Quality of Life Research · 2017 · 58 citations

Medicine, Gynecology, Oncology +17